Targeting fungal-specific biological pathways, such as chitin synthesis or virulence factor secretion, offers opportunities for designing highly selective and less toxic agents (Zhu et al., 2023)
To study the role of GIP in the response to linagliptin, mice were administered a GIP receptor-antagonising antibody (GIPrAb
Written by Dr
Indeed, liraglutide, the first GLP- 1 RA approved for chronic weight management (in 2014) was shown in the SCALE Phase 3 trial to produce mean weight reduction from baseline to week 56, of 8.0% with liraglutide 3.0 mg versus 2.8% with placebo (last-observation-carried-forward imputationLOCF) [3]
(Boraginaceae)] which is commonly used as an antiinflammatory or detoxicant agent, showed significantly reduced serum concentrations of ALT, AST, ALP, and inflammatory markers (Teng et al., 2012)